Get the app
US › Healthcare

Lunai Bioworks Inc. (LNAI)

US · Healthcare · Biotechnology

—

Latest quarter · ended 2026-06-30

Revenue
$31,050
Net profit
$-2.0M
Net margin
-6,475.7%

Key statistics

Market cap
$829,677
Forward P/E
0.0
P/B
0.48
Book value
$-1.96
EPS (TTM)
$-1.06
52-week high
$5.02
52-week low
$0.15
50-day MA
$1.61
200-day MA
$2.79
Beta
0.36

Shareholding

Insiders
37.48%
Institutions
3.92%

Largest institutional holders

FundStake
Ground Swell Capital, LLC1.17%
State Street Corp0.83%
Geode Capital Management, LLC0.53%
Jane Street Group LLC0.52%
Vanguard Capital Management, LLC0.35%
BlackRock Inc0.35%
Virtu Financial LLC0.28%
Vanguard Fiduciary Trust Co0.19%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lunai Bioworks Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.